Risk of Crohn ' s Disease or UC With Anti-TNFa Agents Risk of Crohn ' s Disease or UC With Anti-TNFa Agents
Is there an increased risk of developing de novo inflammatory bowel disease while under treatment with anti-TNF-alpha for other chronic inflammatory or immune-mediated diseases?Alimentary Pharmacology & Therapeutics
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Gastroenterology Journal Article Source Type: news
More News: Allergy | Allergy & Immunology | Crohn's Disease | Drugs & Pharmacology | Gastroenterology | Inflammatory Bowel Disease